Information, support and friendship
AMEND is run by patients, for patients, to inform and support anyone affected by Multiple Endocrine Neoplasia (MEN) types 1, 2 and 3 and associated endocrine syndromes and tumours.
We are here to break the isolation so often felt by those with these rare diseases, and we would be delighted to welcome you into our 'family'.
The aim of our website is to direct you as quickly as possible to our support services and to information you can trust on MEN1, MEN2, MEN3, MTC (medullary thyroid cancer), FMTC (familial medullary thyroid cancer), adrenal gland tumours (phaeochromocytomas), parathyroid hyperplasia, paragangliomas, FIPA (familial isolated pituitary adenoma) and SDHx (succinate dehydrogenase) disorders.
September Members' Newsletter Available
The latest AMEND newsletter for members is now available to view on this website.
As usual it is packed with exciting news, project updates, My Story and much more!
Members are reminded to log in first to view the latest newsletter.
Membership is free if you have not yet joined.
We hope you enjoy reading this latest edition.
September is Thyroid Cancer Awareness Month
Thyroid cancer is being diagnosed in greater numbers than ever before.
Differentiated thyroid cancer can affect anyone in the general population and if found early, can often be treated successfully.
Undifferentiated medullary thyroid cancer affects people with MEN type 2 and treatment differs from that for other thyroid cancers.
Find links to further information and advice on what you can do, including Check Your Neck, on our webpage.
Page 1 of 16